CRC has an immunosuppressive TME which stops the development of a powerful reaction to ICB therapies. There's Hence an urgent should discover the ways reprogram this suppressive TME to be able to enhance immunotherapy efficacy. In the current study, we employed CRISPR KO screens to discover genes that sensitize CRC https://garryy863otx6.blogscribble.com/profile